![Tord Labuda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tord Labuda
Amministratore Delegato presso
ALZINOVA AB
Profilo
Tord Labuda is Chief Executive Officer at Alzinova AB since 2024.
Formerly, Dr. Labuda was Independent Director at NanoEcho AB from 2023 to 2026 and Vice President & Global Head-Clinical Development at LEO Pharma A from 2008 to 2023.
Education includes a doctorate from the University of Lund.
Posizioni attive di Tord Labuda
| Società | Posizione | Inizio |
|---|---|---|
| ALZINOVA AB | Amministratore Delegato | 01/10/2024 |
Precedenti posizioni note di Tord Labuda
| Società | Posizione | Fine |
|---|---|---|
| NANOECHO AB | Direttore/Membro del Consiglio | 28/05/2026 |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Corporate Officer/Principal | 01/01/2023 |
Formazione di Tord Labuda
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
57
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Nanoecho AB
 Nanoecho AB Medical SpecialtiesHealth Technology Develops medical ultrasound imaging equipment to treat rectal cancer | Health Technology |
